Peripancreatic Castleman's disease approached by videolaparoscopy: A case report

Authors

DOI:

https://doi.org/10.33448/rsd-v13i8.46555

Keywords:

Castleman's disease; Peripancreatic lymph node; General surgery.

Abstract

Castleman's disease is an uncommon medical condition characterized by abnormal growth of lymphatic cells. Also called giant nodular hyperplasia or lymphoid angiofollicular hyperplasia, it can result in increased lymphoid tissue and tumor formation. The present study aims to report the case of a patient diagnosed with Castleman's disease after an incidental finding on an imaging exam and describe its manifestations, radiological findings, and approaches. Methodology: data collection will take place in the patient's medical records at a hospital in Patos de Minas, during July and November 2023, after obtaining parental consent and patient assent. Information such as sex, age, date of diagnosis, symptoms, and imaging exam results will be recorded and presented descriptively through a case report. In addition, a search will be carried out in the Google Academy, Scielo, Pubmed, BVS, and LILACS databases to gather relevant national and international articles to enrich the research.

References

Caprio, J., et al. (2016). Doença de Castleman: relato de caso [Castleman’s disease: case report]. Revista da Sociedade Brasileira de Clínica Médica, 14(3), 163–168.

Carbone, A., Borok, M., Damania, B., et al. (2021). Castleman disease. Nature Reviews Disease Primers, 7, 84. https://doi.org/10.1038/s41572-021-00282-3

Cardwell, M., et al. (2023). Um caso de doença de Castleman unicêntrica com miastenia gravis concomitante e veia cava superior esquerda persistente. Revista Americana de Relatos de Casos, 24, e938305. https://doi.org/10.3892/brc.2023.938305

Chan, K. L., et al. (2016). Update and new approaches in the treatment of Castleman disease. Journal of Blood Medicine, 7, 145–158. https://doi.org/10.2147/JBM.S103425

Chen, J., Liu, X., Wang, H., & Zhao, Y. (2022). Laparoscopic management of peripancreatic Castleman disease: A case report and literature review. Cases Journal, 15, rjae073. https://doi.org/10.1186/s13256-022-02883-x

Diniz, D., & Corrêa, M. (2001). Declaração de Helsinki: relativismo e vulnerabilidade. Cadernos de Saúde Pública, 17(3), 679-688.

Dispenzieri, A., & Fajgenbaum, D. C. (2020). Overview of Castleman disease. Blood, 135(16), 1353-1364. https://doi.org/10.1182/blood.2020004820

Forteski, D. de F., et al. (2014). Doença de Castleman multicêntrica não associada aos vírus HHV-8 e HIV. Revista Brasileira de Reumatologia, 54, 326–329. https://doi.org/10.1016/j.rbre.2014.02.006

González García, A., Fernández-Martín, J., & Robles Marhuenda, Á. (2022). Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: Practical guidance for diagnosis. Rheumatology. https://doi.org/10.1093/rheumatology/keac234

Haap, M., et al. (2018). Achados clínicos, laboratoriais e de imagem na doença de Castleman: O subtipo decide. Sangue Revista, 32(3), 225–234. https://doi.org/10.1016/j.sangre.2018.02.004

Hakozaki, M., et al. (2010). Doença de Castleman intramuscular do deltoide: relato de caso e revisão da literatura. Radiologia Esquelético, 39(7), 715–719. https://doi.org/10.1590/S1678-44642010000700007

Madan, R., et al. (2012). O espectro da doença de Castleman: mímica, correlação radiológica patológica e papel da imagem no manejo do paciente. European Journal of Radiology, 81(1), 123–131. https://doi.org/10.1016/j.ejrad.2011.01.008

Ostrowska, B., Szymczyk, A., Olszewska-Szopa, M., et al. (2021). Efficacy of siltuximab in the treatment of idiopathic multicentric Castleman disease, the first Polish, real-world experience with long-term observation. Leukemia & Lymphoma, 62(12), 3031-3034. https://doi.org/10.1080/10428194.2021.1919810

Ozturk, E., Abdullayev, R., Gungor, B., & Ozdemir, C. (2023). Unicentric Castleman’s disease in the peripancreatic region: A laparoscopic case report. American Journal of Case Reports, 24, e935279. https://doi.org/10.12659/AJCR.935279

Pereira, A. S., et al. (2018). Metodologia da pesquisa científica. UFSM.

Porto, L. G. (2018). Doença de Castleman (TCC). Instituto Nacional de Câncer José Alencar Gomes da Silva.

Tanaka, Y., Shinohara, T., & Kimura, M. (2021). Unicentric Castleman’s disease mimicking pancreatic neoplasm: A case report. Journal of Surgical Case Reports, 2021(2), rjaa017. https://doi.org/10.1093/jscr/rjaa017

van Rhee, F., Oksenhendler, E., Srkalovic, G., et al. (2020). International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Advances, 4(23), 6039-6050. https://doi.org/10.1182/bloodadvances.2020002705

Van Rhee, F., et al. (2020). Consensos internacionais baseados em evidências para diagnóstico e diretrizes de tratamento da doença de Castleman unicêntrica. Blood Advances, 4(23), 6039–6050. https://doi.org/10.1182/bloodadvances.2020002705

Zhang, L., Dong, Y., Peng, H., et al. (2022). A National, Multicenter, Retrospective Study of Castleman Disease Implementing CDCN Criteria: ‘severe iMCD’ is indeed severe. Blood, 140(24), 3609-3611. https://doi.org/10.1182/blood.2022007645

Zhang, W., & Wei, L. (2019). Primary Castleman disease in peripancreatic tissue regarded as pancreatic malignance: A case report. American Journal of Case Reports, 20, e921435. https://doi.org/10.12659/AJCR.921435

Downloads

Published

13/08/2024

How to Cite

SOARES, C. E. M. .; ROCHA, G. V. .; FURTADO, J. G. .; LEGATTI, J. N. .; ANTONACCI JUNIOR, E. . Peripancreatic Castleman’s disease approached by videolaparoscopy: A case report. Research, Society and Development, [S. l.], v. 13, n. 8, p. e4913846555, 2024. DOI: 10.33448/rsd-v13i8.46555. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/46555. Acesso em: 5 jan. 2025.

Issue

Vol. 13 No. 8

Section

Health Sciences

License

Copyright (c) 2024 Carlos Eduardo Melo Soares; Giovana Vilela Rocha; Júlia Guerra Furtado; Júlia Nascimento Legatti; Edson Antonacci Junior

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.